Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Applied Genomics, |
RCV001268478 | SCV001447434 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001389448 | SCV001590822 | pathogenic | Joubert syndrome 23; Short-rib thoracic dysplasia 14 with polydactyly | 2022-09-21 | criteria provided, single submitter | clinical testing | This sequence change affects codon 605 of the KIAA0586 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the KIAA0586 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs762081862, gnomAD 0.005%). This variant has been observed in individuals with short-rib thoracic dysplasia (PMID: 2080096, 26166481). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 208813). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in exon 14 skipping and introduces a premature termination codon (PMID: 26166481). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. |
Equipe Genetique des Anomalies du Developpement, |
RCV000190841 | SCV003920928 | pathogenic | Short-rib thoracic dysplasia 14 with polydactyly | 2022-07-27 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000190841 | SCV000245711 | pathogenic | Short-rib thoracic dysplasia 14 with polydactyly | 2015-08-06 | no assertion criteria provided | literature only |